GENE THERAPY OF INHERITED ENZYME DEFICIENCIES
GENE THERAPY OF INHERITED ENZYME DEFICIENCIES
批准号:
6111859
负责人:
R O BRADY
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
CD34 molecule Fabry's disease Gaucher's disease cell transplantation clinical research clinical trial phase I enzyme activity enzyme deficiency gene expression gene mutation gene targeting gene therapy genetic disorder genetic transduction glucosylceramidase hematopoietic stem cells hematopoietic tissue transplantation human subject human therapy evaluation inborn metabolism disorder laboratory mouse macrophage molecular cloning tissue /cell culture transfection /expression vector
中文摘要
我们已经完成了一期安全性和基因试验
英文摘要
We have completed a Phase 1 safety and gene trial
in patients with Type 1 Gaucher disease. CD34+ stem and
progenitor cells were obtained from peripheral blood by apheresis
after stimulating patients with G-CSF (NIH) or from bone marrow
biopsies (Children's Hospital, Los Angeles). The first recipient was
a 21-year-old male with Type 1 Gaucher disease where only bone
marrow stromal cells were used in the expansion of his CD34+
cells. Barely detectable and short-lasting marking of granulocytes
was observed. The second patient was a 22-year-old female.
Autologous marrow stromal cells along with IL-3, IL-6 and SCF
were employed to expand the transduced cells. More significant and
longer lasting granulocyte marking was observed in this patient. We
are developing more efficient procedures to infect CD34+ cells and
to segregate the transduced cells. We are also investigating
methods to provide a growth advantage to the transduced cells. We
have carried out a series of pre-clinical investigations concerning
gene therapy for Fabry disease. A recombinant retroviral gene
transfer vector was designed that engineers efficient traduction of
cells and expression of human alpha-Gal A activity. Enzymatic
correction was observed in cultured skin fibroblasts and B cell lines
derived from patients with Fabry disease. Corrected cells secreted
significant quantities of alpha-Gal A into the culture medium, and
the enzyme is taken up by uncorrected bystander cells. We have
also achieved enzymatic correction in CD34+ and progenitor
colony cells obtained from bone-marrow aspirates from patients
with Fabry disease. We are producing a high-titer clinical grade
vector under GMP conditions for gene therapy trials in Fabry
disease. We shall also explore gene therapy in the transgenic
alpha-Gal A knock-out mouse model of Fabry disease that we
created. In addition, we have made gene transfer vector constructs
based on HIV-1 that are highly effective in the transduction of
quiescent cells including rat cerebellar neurons. This investigation
has particular relevance to gene therapy since most stem cells in the
bone marrow are non-dividing and cells within the nervous system
are in the post- mitotic state.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ENZYME REPLACEMENT THERAPY IN DISORDERS THAT AFFECT THE CENTRAL NERVOUS SYSTEM
-
批准号:5203975
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R O BRADY
-
依托单位:
ENZYME REPLACEMENT THERAPY IN DISORDERS THAT AFFECT THE CENTRAL NERVOUS SYSTEM
-
批准号:6163060
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R O BRADY
-
依托单位:
ENZYME REPLACEMENT THERAPY IN AN ANALOGUE OF HUMAN GM1 GANGLIOSIDOSIS
-
批准号:3760329
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R O BRADY
-
依托单位:
ENZYME REPLACEMENT THERAPY IN AN ANALOGUE OF HUMAN GM1 GANGLIOSIDOSIS
-
批准号:3782429
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R O BRADY
-
依托单位:
ENZYME REPLACEMENT THERAPY IN DISORDERS THAT AFFECT THE CENTRAL NERVOUS SYSTEM
-
批准号:2579614
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R O BRADY
-
依托单位:
DEVELOPMENT OF ENZYMES THAT INACTIVATE NEUROTOXIC AGENTS
-
批准号:4696902
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R O BRADY
-
依托单位:
METABOLISM OF COMPLEX LIPIDS OF NERVOUS TISSUES
-
批准号:3922451
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R O BRADY
-
依托单位:
EXPLORATION OF STRATEGIES FOR THE TREATMENT OF AIDS
-
批准号:3922644
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R O BRADY
-
依托单位:
MODIFICATION OF BRAIN SPECIFIC CYCLIN DEPENDENT KINASE GENES
-
批准号:6111916
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R O BRADY
-
依托单位:
GENETIC THERAPY OF FABRY DISEASE
-
批准号:2579673
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R O BRADY
-
依托单位:
INVESTIGATION OF THE ETIOLOGY OF MUCOLIPIDOSIS IV
-
批准号:3846319
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R O BRADY
-
依托单位:
GAUCHER'S DISEASE--BIOCHEMICAL AND CLINICAL STUDIES
-
批准号:3881725
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R O BRADY
-
依托单位:
GENETIC THERAPY OF FABRY DISEASE
-
批准号:5204033
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R O BRADY
-
依托单位:
METABOLISM OF COMPLEX LIPIDS OF NERVOUS TISSUES
-
批准号:3945163
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R O BRADY
-
依托单位:
INVESTIGATION OF THE ETIOLOGY OF MUCOLIPIDOSIS IV
-
批准号:3782427
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R O BRADY
-
依托单位:
GENERATION OF MOUSE MODELS OF NEUROLOGICAL DISORDERS
-
批准号:6163090
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R O BRADY
-
依托单位:
MODIFICATION OF BRAIN SPECIFIC CYCLIN DEPENDENT KINASE GENES
-
批准号:6163089
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R O BRADY
-
依托单位:
GENETIC THERAPY OF FABRY DISEASE
-
批准号:6163104
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R O BRADY
-
依托单位:
GAUCHER'S DISEASE--BIOCHEMICAL AND CLINICAL STUDIES
-
批准号:3922532
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R O BRADY
-
依托单位:
METABOLISM OF COMPLEX LIPIDS OF NERVOUS TISSUES
-
批准号:3881663
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R O BRADY
-
依托单位:
海外基金